MedTrace Logo

Contraception and Pregnancy in Diabetes Mellitus

NCT04523454 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 96

Last updated 2024-09-23

Study results available
· View outcomes & findings →

Summary

This study seeks to expand upon and update this body of work. It will explore the knowledge and understanding women with diabetes have around pregnancy and conception, as well as establish how well prepared these women are for a pregnancy. Using this data, we will develop better services to inform women with diabetes about the contraception and pregnancy, as well inform the development of pre-conception counselling services for women with diabetes. If successful, we would anticipate seeing an improvement in performance in future National Diabetes in Pregnancy audits.

Conditions

  • Diabetes Mellitus, Type 1
  • Contraception

Sponsors & Collaborators

  • Imperial College London

    lead OTHER

Principal Investigators

  • Rochan Agha-Jaffar · Imperial College Healthcare NHS Trust

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-02
Primary Completion
2021-08-01
Completion
2021-08-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04523454 on ClinicalTrials.gov